文献速递支持与姑息治疗

肠外阿片类药物短缺对转诊姑息治疗的住院癌症患者处方模式及疼痛控制的影响

Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care.
PubMed 文献 · JAMA Oncol · 2019-01-01

该队列研究纳入386例在综合癌症中心接受住院姑息治疗(PC)的癌症患者,比较2018年2月8日本机构宣布肠外阿片类药物短缺(POS)前后1个月的阿片处方模式及临床疼痛改善(CIP)。POS后转诊肿瘤团队和PC团队开具肠外阿片类药物的比例均显著下降,随访第1天达到CIP的患者比例显著降低(62% vs 75%)。多因素分析显示POS前患者达到CIP的几率高89%(OR 1.89,95%CI 1.22-2.94,P=.005)。

要点

  • POS后转诊肿瘤团队开具肠外阿片类药物比例由35%(109/311)降至18%(56/314)(P<.001)。
  • POS后PC团队开具肠外阿片类药物比例由47%(159/338)降至29%(96/336)(P<.001)。
  • POS后随访第1天达到CIP的患者比例由75%(144/193)降至62%(119/193)(P=.01)。

核心结论

  • POS与阿片处方模式显著改变相关,且POS后达到CIP的患者更少。

研究设计与样本

  • 队列研究,纳入386例在综合癌症中心接受住院PC治疗的癌症患者,比较机构首次报告POS前1个月与后1个月。

主要发现

  • POS后转诊肿瘤团队开具肠外阿片类药物比例低于POS前:56/314(18%)vs 109/311(35%)(P<.001)。
  • POS后PC团队开具肠外阿片类药物比例低于POS前:96/336(29%)vs 159/338(47%)(P<.001)。
  • POS后随访第1天达到CIP的患者比例低于POS前:119/193(62%)vs 144/193(75%)(P=.01)。
  • 多因素分析显示POS前患者随访第1天达到CIP的几率更高(OR 1.89,95%CI 1.22-2.94,P=.005)。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The recent parenteral opioid shortage (POS) has potential implications for cancer-related pain management in hospitalized patients. OBJECTIVE: This study compared changes in opioid prescriptions and clinically improved pain (CIP) among patients treated by an inpatient palliative care (PC) team before and after our institution first reported the POS. DESIGN, SETTING, AND PARTICIPANTS: A cohort study of 386 eligible patients with cancer treated at a comprehensive cancer center 1 month before and after the announcement of the POS. We reviewed data from electronic health records, including patient demographics, opioid type, route of administration, and dose. Board-certified palliative care specialists assessed CIP at follow-up day 1. EXPOSURES: The announcement of the POS by the institution's pharmacy and therapeutics committee on February 8, 2018. MAIN OUTCOMES AND MEASURES: The primary outcome was to measure the change in opioid prescription patterns of physicians, and the secondary outcome was to measure the proportion of patients who achieved CIP before and after announcement of the POS. RESULTS: Of 386 eligible patients, 196 were men (51%), 270 were white (70%), and the median age was 58 years (interquartile range, 46-67 years). Parenteral opioids were prescribed less frequently by the referring oncology teams after the POS (56 of 314 [18%]) vs before the POS (109 of 311 [35%]) (P < .001). The PC team also prescribed fewer parenteral opioids after the POS (96 of 336 [29%]) vs before the POS (159 of 338 [47%]) (P < .001). After the POS (vs before the POS), significantly fewer patients achieved CIP on follow-up day 1 (119 [62%] vs 144 [75%] of 193; P = .01). Multivariate analysis showed that before the POS, patients had an 89% higher chance of achieving CIP on follow-up day 1 (odds ratio, 1.89; 95% CI, 1.22-2.94; P = .005). CONCLUSIONS AND RELEVANCE: There was a significant change in opioid prescription patterns associated with the POS. Furthermore, after the POS, fewer patients achieved CIP. These factors have potential implications for patient satisfaction and hospital length of stay.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Haider A, Qian Y, Lu Z, et al. Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care. JAMA Oncol. 2019. PMID: 30896771. doi:10.1001/jamaoncol.2019.0062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。